These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24465655)

  • 21. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients.
    Ceyhan C; Unal S; Yenisey C; Tekten T; Ceyhan FB
    Int J Cardiovasc Imaging; 2008 Mar; 24(3):253-9. PubMed ID: 17687631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives.
    Sarzani R; Dessì-Fulgheri P; Salvi F; Serenelli M; Spagnolo D; Cola G; Pupita M; Giantomassi L; Rappelli A
    J Hypertens; 1999 Sep; 17(9):1301-5. PubMed ID: 10489108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of pro B-natriuretic peptide in hypertensive patients with and without diastolic dysfunction.
    Santosa YP; Tjandrawati A; Noormartany ; Erwinanto ; Yahya AF; Martanto E; Tedjokusumo P; Purnomowati A; Antono E
    Acta Med Indones; 2008 Jan; 40(1):19-23. PubMed ID: 18326895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting.
    Fox AA; Collard CD; Shernan SK; Seidman CE; Seidman JG; Liu KY; Muehlschlegel JD; Perry TE; Aranki SF; Lange C; Herman DS; Meitinger T; Lichtner P; Body SC
    Anesthesiology; 2009 Apr; 110(4):738-47. PubMed ID: 19326473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of N-terminal pro-brain natriuretic peptide in the evaluation of postoperative left ventricular diastolic dysfunction.
    Islamoglu F; Ozcan K; Apaydin AZ; Soydas C; Bayindir O; Durmaz I
    Tex Heart Inst J; 2008; 35(2):111-8. PubMed ID: 18612440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natriuretic peptide receptor-3 gene (NPR3): nonsynonymous polymorphism results in significant reduction in protein expression because of accelerated degradation.
    Pereira NL; Lin D; Pelleymounter L; Moon I; Stilling G; Eckloff BW; Wieben ED; Redfield MM; Burnett JC; Yee VC; Weinshilboum RM
    Circ Cardiovasc Genet; 2013 Apr; 6(2):201-10. PubMed ID: 23493048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposite associations of circulating aldosterone and atrial natriuretic peptide with left ventricular diastolic function in essential hypertension.
    Fagard RH; Lijnen PJ; Petrov VV
    J Hum Hypertens; 1998 Mar; 12(3):195-202. PubMed ID: 9579770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
    Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of change in 5-year N-terminal fragment of the prohormone brain-type natriuretic peptide with left ventricular structure and function in stable coronary disease.
    Psotka MA; Schiller NB; Whooley MA; Mishra RK
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19(2):67-72. PubMed ID: 29251695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]).
    Mishra RK; Li Y; Ricardo AC; Yang W; Keane M; Cuevas M; Christenson R; deFilippi C; Chen J; He J; Kallem RR; Raj DS; Schelling JR; Wright J; Go AS; Shlipak MG;
    Am J Cardiol; 2013 Feb; 111(3):432-8. PubMed ID: 23178053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systolic and diastolic heart failure in the community.
    Bursi F; Weston SA; Redfield MM; Jacobsen SJ; Pakhomov S; Nkomo VT; Meverden RA; Roger VL
    JAMA; 2006 Nov; 296(18):2209-16. PubMed ID: 17090767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
    Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natriuretic peptide receptor 3 (NPR3) is regulated by microRNA-100.
    Wong LL; Wee AS; Lim JY; Ng JY; Chong JP; Liew OW; Lilyanna S; Martinez EC; Ackers-Johnson MA; Vardy LA; Armugam A; Jeyaseelan K; Ng TP; Lam CS; Foo RS; Richards AM; Chen YT
    J Mol Cell Cardiol; 2015 May; 82():13-21. PubMed ID: 25736855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of Development of Echocardiographic Left Ventricular Diastolic Dysfunction in the Subjects Aged 40 to 59 Years (from the Oulu Project Elucidating Risk of Atherosclerosis Study).
    Perkiömäki JS; Möttönen M; Lumme J; Kesäniemi YA; Ukkola O; Huikuri HV
    Am J Cardiol; 2015 Nov; 116(9):1374-8. PubMed ID: 26341186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
    Loke I; Squire IB; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation to NT-ProBNP and remodeling after cardiac surgery.
    Boer BP; Vieira ML; Sampaio RO; Abensur H; Oliveira AG; Fernandes JR; Grinberg M
    Arq Bras Cardiol; 2013 May; 100(5):469-75. PubMed ID: 23579620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects.
    Lim HS; Patel JV; Nadar S; Hughes EA; Lip GY
    Am J Cardiol; 2005 Apr; 95(7):905-8. PubMed ID: 15781031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.